FDA inspection
Nanjing Hanxin Pharmaceutical Technology Co., Ltd.: FDA inspection ending Mar 28, 2025
FDA inspection 1269301 · Qixia, Nanjing
Key facts
| Inspection ID | 1269301 |
|---|---|
| Firm | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. |
| FEI number | 3015142388 |
| Address | Building C5, No. 9 Weidi Road, Xianlin University Town, Xianlin Street |
| City | Qixia, Nanjing |
| Fiscal year | 2025 |
| Inspection end date | Mar 28, 2025 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data